Search results
FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests
The National Law Review· 10 hours agoYesterday, the Food & Drug Administration (“FDA” or “the Agency”) issued a highly anticipated – and...
FDA, doctors warn about compounded Ozempic. What we found at metro weight loss clinics
WFTV via Yahoo News· 8 hours agoIt’s a popular drug that millions of people are taking to lose weight, but the federal government...
FDA Finally Moves to Scrutinize Specialized Health Screenings
ProPublica· 2 hours ago“This is a significant step forward,” said Peter Lurie, president and executive director of the...
It’s Been a Long Time Coming – FDA’s Final Rule on Regulation of Laboratory Developed Tests (LDTs)...
The National Law Review· 14 hours agoToday, on April 29, 2024, following more than a decade of discourse, the U.S. Food and Drug...
FDA approves INGREZZA SPRINKLE for swallowing difficulties By Investing.com
Investing.com· 10 hours agoNeurocrine (NASDAQ:NBIX) Biosciences, Inc. (NASDAQ:NBIX) today announced that the U.S. Food and Drug...
FDA approves Neurocrine Biosciences' Huntington's disease drug
Reuters via Yahoo Finance· 10 hours agoApril 30 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved granule formulation of Neurocrine Biosciences' drug to treat movement disorders ...
FDA finalizes lab test regulations with more flexibility
Politico· 15 hours agoDiana DeGette (D-Colo.) and Larry Bucshon (R-Ind.) — co-sponsors of legislation known as the VALID Act — said that while they are disappointed with the rule, they “recognize that FDA ...
FDA finalizes rule to increase oversight of lab tests
Boston Herald· 13 hours agoThe rule effectively reclassifies tests developed and performed in a lab as medical devices for the...
Beloved high school football coach who couldn’t get chemotherapy drug due to national shortage dead...
New York Post· 1 hour agoWilliam Dahut, chief scientific officer of the American Cancer Society, told TODAY. Fifteen oncology...
Neurocrine Biosciences’ Huntington’s disease drug gets FDA approval
WSAU Wausau· 7 hours agoBy Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza ...